KBLB · Kraig Biocraft Laboratories, Inc.
$0.09
+0.00 (+1.42%)
At close · Aug 28
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“This raises substantial doubt about its ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company's ability to raise additional capital and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Management believes that actions presently being taken to obtain additional funding and implement its strategic plans provide the opportunity for the Company to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$100.38M
Shares
1.12B
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$401.62K
+312.7%
FY2018
Net Income
-$3.62M
-6.6%
FY2025
Operating Margin
-239.02%
+1976.4pp
FY2018
Diluted EPS
$0.00
FY2025
Operating Cash Flow
-$1.79M
+2.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | $401.62K | $97.32K | $31.86K | $0 | $0 | $0 | $0 | $0 | — | — | — | — | |
| $209.06K | $165.76K | $164.37K | $237.87K | $176.43K | $197.75K | $88.47K | $223.05K | $148.07K | $258.89K | $397.14K | $432.01K | $439.54K | $489.43K | $465.29K | $250.6K | $141.31K | — | — | — | |
| $2.18M | $1.96M | $1.75M | $1.45M | $825.46K | $1.5M | $3.52M | $1.41M | $515.88K | $1.22M | $1.74M | $920.92K | $896.08K | $1.31M | $379.33K | $786.91K | $591.02K | — | — | — | |
| $29.27K | — | — | — | — | — | — | — | $26.63K | $20.29K | $16.97K | $15.42K | $7159 | $5888 | $5583 | $5370 | — | — | — | — | |
| $3.69M | $3.37M | $3.07M | $2.61M | $2.12M | $2.76M | $4.53M | $2.62M | $1.36M | $2.25M | $2.98M | $2.05M | $1.83M | $2.21M | $1.56M | $1.3M | $1.29M | — | — | — | |
| -$3.69M | -$3.37M | -$3.07M | -$2.61M | -$2.12M | -$2.76M | -$4.53M | -$2.62M | -$959.95K | -$2.16M | -$2.95M | -$2.05M | -$1.83M | -$2.21M | -$1.56M | -$1.3M | -$1.29M | — | — | — | |
| — | — | — | — | — | — | — | — | -239.02% | -2215.41% | -9246.04% | — | — | — | — | — | — | — | — | — | |
| -$2.21M | — | — | — | — | — | — | — | -$933.32K | -$2.14M | -$2.93M | -$2.04M | -$1.83M | -$2.21M | -$1.55M | -$1.29M | — | — | — | — | |
| $588.21K | $570.71K | $529.6K | $484.66K | — | — | — | $294.35K | $228.95K | $177.11K | $139.43K | $101.55K | $69.28K | $65.61K | $45.71K | $0 | $52.38K | — | — | — | |
| $132.5K | — | — | $109.56K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$463.95K | -$248.56K | -$324.38K | -$414.99K | -$1.72M | -$5.29M | -$437.13K | -$287.98K | -$209.03K | -$177.11K | -$128.24K | -$79.25K | -$38.63K | -$5.25M | -$42.52K | $2100 | -$496.46K | — | — | — | |
| -$4.15M | -$3.62M | -$3.4M | -$3.03M | -$3.84M | -$8.05M | -$4.97M | -$2.91M | -$1.17M | -$2.33M | -$3.07M | -$2.13M | -$1.87M | -$7.47M | -$1.6M | -$1.3M | -$1.78M | — | — | — | |
| $0 | — | — | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — | — | |
| -$4.15M | -$3.62M | -$3.4M | -$3.03M | -$3.84M | -$8.05M | -$4.97M | -$2.91M | -$1.17M | -$2.33M | -$3.07M | -$2.13M | -$1.87M | -$7.47M | -$1.6M | -$1.3M | -$1.78M | -$1.43M | -$1.72M | -$472.99K | |
| — | — | — | — | — | — | — | — | -291.07% | -2397.4% | -9648.57% | — | — | — | — | — | — | — | — | — | |
| -$3.87M | — | — | -$3.03M | -$3.84M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| USD/shares | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| USD/shares | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 1.06B | 1.04B | 1.03B | 974.31M | 877.61M | 848.65M | 835.59M | 816.87M | 791.39M | 744.28M | 685.84M | 662.49M | 616.31M | 596.14M | 572.71M | — | — | — | — |
| shares | — | 1.06B | 1.04B | 1.03B | 974.31M | 877.61M | 848.65M | 835.59M | 816.87M | 791.39M | 744.28M | 685.84M | 662.49M | 616.31M | 596.14M | 572.71M | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 2.04×
EV/EBIT
—
Peer median 23.08×
P/E (TTM)
—
Peer median 25.86×
Peer medians compare against the 22 similar-size Specialty Chemicals companies (of 62 listed).